The Whole Toolkit Tested in Carotid Artery Stenting

This study sought to randomly compare the double-layer Roadsaver stent (Terumo) with the single-layer Carotid Wallstent device (Boston) in association with either distal filter-like embolic protection device FilterWire (Boston) or proximal protection device Mo.Ma (Medtronic) in patients with lipid-rich carotid plaques.

Por primera vez un estudio confirma que las pantallas de protección plomadas resguardan de la radiación a todo el personal de la sala de cateterismos

This is a very interesting work because there are no head-to-head simultaneous comparisons between these stent types and these brain protection systems: we only had physiopathological speculation.

A total of 104 consecutive patients were randomized to carotid artery stenting with FilterWire + Roadsaver stent (group 1, n = 27), FilterWire + Wallstent (group 2, n = 25), Mo.Ma + Roadsaver stent (group 3, n = 27), or Mo.Ma + Wallstent (group 4, n = 25).

The primary endpoint was the number of microembolic signals on transcranial Doppler in each procedural step: target vessel access; lesion wiring; pre-dilation; stent crossing; stent deployment; post-dilation, and device retrieval.


Read also: Crest-2 Registry: Carotid PCI Presents Low Rates of Death and Stroke.


The Mo.Ma was significantly superior to the FilterWire device in the reduction of microembolic signals (p < 0.0001) during lesion crossing, stent crossing, stent deployment, and post-dilation.

The Roadsaver was significantly superior to the Wallstent device (p = 0.016) during stent deployment and device retrieval. It also reduced the number of spontaneous microembolic signals (29% of patients).

The combination of proximal protection device Mo.Ma and double-layer stent Roadsaver was superior (p = 0.043) to all other combinations.


Read also: New Device for More Protection in Carotid Artery Stenting.


These were the differences found regarding microembolic signals on transcranial Doppler, but there were no clinical differences.

After stenting, peak systolic velocity decreased in all patients. At 6 months, only one patient experienced restenosis.

Conclusion

In patients with high-risk, lipid-rich carotid plaque, angioplasty combining proximal protection device Mo.Ma and double-layer stent Roadsaver resulted in the lowest number of microembolic signals on transcranial Doppler.

Original title: Carotid Wallstent Versus Roadsaver Stent and Distal Versus Proximal Protection on Cerebral Microembolization During Carotid Artery Stenting.

Reference: Piero Montorsi et al. J Am Coll Cardiol Intv 2020;13:403–14.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...